Mitoxantrone Side Effects
>>>Help Community - Post Your Mitoxantrone Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Mitoxantrone Side Effects
Mitoxantrone Safety Reports reported to FDA
Total Mitoxantrone reports: 48.Mitoxantrone FDA safety alerts: 2005 .
Reported deaths: 14 Reported hospitalizations: 20.
Take Mitoxantrone Side Effects Survey or Share Your Mitoxantrone Story.
Reported Mitoxantrone Side Effects: acute promyelocytic leukaemia, acute myeloid leukaemia, febrile neutropenia, pulmonary alveolar haemorrhage, hypotension, ventricular hypokinesia, endocardial fibrosis, ejection fraction decreased, torsade de pointes, condition aggravated, myocardial infarction.
Mitoxantrone Usage.
If you have questions about Mitoxantrone, you can post them to our Doctors or Ask Patient Community about Mitoxantrone.
Mitoxantrone Side Effects Report #5218957-8
Physician from UNITED STATES reported MITOXANTRONE problem on Jan 12, 2007. Female patient, weighting 116.0 lb, was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: asthenia, b-cell lymphoma stage iv, diabetes mellitus, follicle centre lymphoma diffuse small cell lymphoma, haemoglobin decreased, pyrexia, weight decreased. MITOXANTRONE dosage: 8MG/M2, DAY 2 ONLY, IV. During the same period patient was treated with PROCRIT, RED BLOOD CELLS, RITUXIMAB, FLUDARABINE, OXALIPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5219117-7
MITOXANTRONE problem was reported by a Physician from UNITED STATES on Jan 24, 2007. Female patient, 64 years of age, weighting 168.0 lb, was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: lung adenocarcinoma. MITOXANTRONE dosage: 22 MG X3 EVERY MONTHS IV. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5232282-0
Consumer or non-health professional from ITALY reported MITOXANTRONE problem on Jan 23, 2007. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, anaemia, hepatomegaly, leukopenia, pallor, thrombocytopenia. MITOXANTRONE dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, INTERFERON BETA. Patient recovered.
Mitoxantrone Side Effects Report #5232288-1
MITOXANTRONE problem was reported by a Consumer or non-health professional from ITALY on Jan 23, 2007. Female patient, 21 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, disseminated intravascular coagulation, fatigue, gingival bleeding, hepatosplenomegaly, hyperhidrosis, marrow hyperplasia. MITOXANTRONE dosage: unknown. During the same period patient was treated with INTERFERON BETA. Patient recovered.
Mitoxantrone Side Effects Report #5235117-5
Consumer or non-health professional from CANADA reported MITOXANTRONE problem on Jan 29, 2007. Female patient, 32 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, cardiac failure, cardiogenic shock, cardiotoxicity, cough, disseminated intravascular coagulation, dyspnoea, hypotension. MITOXANTRONE dosage: 8 MG/M2 MONTHLY UNK. Patient died on 01/01/2007.
Mitoxantrone Side Effects Report #5237935-6
MITOXANTRONE problem was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2007. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia, pyrexia. MITOXANTRONE dosage: 18.84 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with BROMAZEPAM, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN AND CODEINE PHOSPHATE, TIANEPTINE, MACROGOL, PARACETAMOL. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5239532-5
Consumer or non-health professional from FRANCE reported MITOXANTRONE problem on Jan 29, 2007. Male patient, 64 years of age, was diagnosed with metastases to bone, prostate cancer metastatic and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant neoplasm progression, prostate cancer. MITOXANTRONE dosage: 12 MG/M2 Q21DAYS IV. During the same period patient was treated with DOCETAXEL, IROFULVEN, CAPECITABINE. Patient died.
Mitoxantrone Side Effects Report #5281062-9
MITOXANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, child 5 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, interstitial lung disease. MITOXANTRONE dosage: 7 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CETIRIZINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, DIFLUCAN, OMEPRAZOLE, PERFALGAN, LAXOBERON, ROCEPHALIN, LEVOLAC. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5284402-X
Physician from UNITED STATES reported MITOXANTRONE problem on Mar 30, 2007. Male patient, 71 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: postoperative wound infection, pyrexia, seroma. MITOXANTRONE dosage: 12MG/M2. During the same period patient was treated with FLUDARABINE, RITUXAN. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5292169-4
MITOXANTRONE problem was reported by a Physician from ITALY on Apr 02, 2007. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. MITOXANTRONE dosage: 7 MG/M^2 - 39 MG. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient recovered.
Mitoxantrone Side Effects Report #5349773-4
Physician from ITALY reported MITOXANTRONE problem on May 29, 2007. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. MITOXANTRONE dosage: 7 MG/M^2 - 39 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.
Mitoxantrone Side Effects Report #5350563-7
MITOXANTRONE problem was reported by a Physician from UNITED STATES on May 21, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, hyperlipidaemia, hypertension, myocardial infarction. MITOXANTRONE dosage: 12MG/M2 EVERY 3 MONTHS. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5350665-5
Physician from ITALY reported MITOXANTRONE problem on May 29, 2007. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. MITOXANTRONE dosage: 7 MG/M^2 - 39 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.
Mitoxantrone Side Effects Report #5358248-8
MITOXANTRONE problem was reported by a Physician from UNITED STATES on May 31, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, b precursor type acute leukaemia, blast cells present, fatigue, myocardial infarction, pancytopenia. MITOXANTRONE dosage: 0.1333 MG/M2 (12 MG/M2, 1 IN 3 M), INJECTION. During the same period patient was treated with INTERFERON. Patient recovered.
Mitoxantrone Side Effects Report #5363028-3
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 04, 2007. Female patient, 40 years of age, was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, hyperlipidaemia, hypertension, myocardial infarction, pancytopenia. MITOXANTRONE dosage: 12 MG/M2, 1 IN 3 MONTHS. Patient recovered.
Mitoxantrone Side Effects Report #5369645-9
MITOXANTRONE problem was reported by a Health Professional from UNITED STATES on June 14, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: central line infection, condition aggravated, febrile neutropenia, hypotension, oxygen saturation decreased, pleural effusion, pneumonia. MITOXANTRONE dosage: 16.7 MG QD IV. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5369888-4
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 11, 2007. Male patient, 43 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt corrected interval prolonged, haemodynamic instability, respiratory distress, torsade de pointes. MITOXANTRONE dosage: unknown. During the same period patient was treated with ARSENIC TRIOXIDE, IDARUBICIN. Patient was hospitalized. Patient died.
Mitoxantrone Side Effects Report #5369889-6
MITOXANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, torsade de pointes. MITOXANTRONE dosage: unknown. During the same period patient was treated with ARSENIC TRIOXIDE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5369890-2
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 11, 2007. Female patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiomyopathy, disease recurrence, hypokalaemia, left ventricular dysfunction, pulmonary haemorrhage, torsade de pointes. MITOXANTRONE dosage: unknown. During the same period patient was treated with ACLARUBICIN, DOXORUBICIN. Patient was hospitalized. Patient died.
Mitoxantrone Side Effects Report #5376676-1
MITOXANTRONE problem was reported by a Consumer or non-health professional from CHINA on June 21, 2007. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with prostate cancer and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: calculus bladder, urinary tract infection, white blood cell count decreased. MITOXANTRONE dosage: 20 MG CYC IV. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5050633-7
Consumer or non-health professional from FRANCE reported MITOXANTRONE problem on June 26, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, bronchial obstruction, leukaemia recurrent, respiratory distress, stenotrophomonas infection. MITOXANTRONE dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died.
Mitoxantrone Side Effects Report #5053621-X
MITOXANTRONE problem was reported by a Physician from GERMANY on Jan 14, 2005. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with breast cancer metastatic, metastases to bone and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: fistula, local anaesthesia, malignant neoplasm progression, osteonecrosis, purulent discharge, wound debridement. MITOXANTRONE dosage: 19.7 MG, UNK. During the same period patient was treated with NAVELBINE, MITOMYCIN, XELODA, FORTECORTIN, AROMASIN, ZOMETA. Patient died on 02/01/2005.
Mitoxantrone Side Effects Report #5061445-2
Pharmacist from UNITED STATES reported MITOXANTRONE problem on July 19, 2006. Male patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. MITOXANTRONE dosage: 20 MG ONCE. During the same period patient was treated with FLUDARABINE. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5081951-4
MITOXANTRONE problem was reported by a Physician from GERMANY on July 31, 2006. Male patient, 40 years of age, was diagnosed with progressive multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, psoriasis. MITOXANTRONE dosage: unknown. Patient recovered.
Mitoxantrone Side Effects Report #5094498-6
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient recovered.
Mitoxantrone Side Effects Report #5094500-1
MITOXANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient recovered.
Mitoxantrone Side Effects Report #5094503-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on Aug 17, 2006. Male patient, 41 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, dysplasia, monocytosis. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient recovered.
Mitoxantrone Side Effects Report #5096493-X
MITOXANTRONE problem was reported by a Health Professional from GERMANY on Aug 17, 2006. Male patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia, cerebral haemorrhage, condition aggravated, retinal haemorrhage. MITOXANTRONE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Mitoxantrone Side Effects Report #5100762-4
Consumer or non-health professional from UNITED KINGDOM reported MITOXANTRONE problem on Aug 22, 2006. Male patient, 53 years of age, was diagnosed with lymphoma and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, steroid withdrawal syndrome. MITOXANTRONE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, FLUDARA. Patient recovered.
Mitoxantrone Side Effects Report #5115566-6
MITOXANTRONE problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Male patient, 41 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient died.
Mitoxantrone Side Effects Report #5115567-8
Physician from UNITED STATES reported MITOXANTRONE problem on Sept 12, 2006. Male patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient died.
Mitoxantrone Side Effects Report #5115568-X
MITOXANTRONE problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Male patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. MITOXANTRONE dosage: 12 MG/M2 OTH. Patient died.
Mitoxantrone Side Effects Report #5121843-5
Health Professional from GERMANY reported MITOXANTRONE problem on Sept 19, 2006. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt corrected interval prolonged. MITOXANTRONE dosage: unknown. Patient recovered.
Mitoxantrone Side Effects Report #5126721-3
MITOXANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Male patient, weighting 201.3 lb, was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity. MITOXANTRONE dosage: 25 MG. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5140962-0
Physician from UNITED STATES reported MITOXANTRONE problem on Oct 27, 2006. Female patient, 46 years of age, weighting 140.0 lb, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: atelectasis, neutropenia, pulmonary embolism, urinary tract infection. MITOXANTRONE dosage: 20 MG Q 3 MONTH I.V.. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5144464-7
MITOXANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Oct 18, 2006. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. MITOXANTRONE dosage: 9 MG/M2. Patient recovered.
Mitoxantrone Side Effects Report #5143520-7
Health Professional from UNITED STATES reported MITOXANTRONE problem on Nov 01, 2006. Female patient, 59 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, pneumonia. MITOXANTRONE dosage: 12 MG/M2 EVERY 3 MONTHS IV DRIP. During the same period patient was treated with TYLENOL, POTASSIUM ACETATE, RESTORIL, LASIX. Patient died on 10/22/2006.
Mitoxantrone Side Effects Report #5158983-0
MITOXANTRONE problem was reported by a Pharmacist from UNITED STATES on Nov 06, 2006. Male patient, 64 years of age, was diagnosed with prostate cancer and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute myeloid leukaemia, blood bilirubin increased, chromosome analysis abnormal, febrile neutropenia, hypotension, hypoxia, lung infiltration, multi-organ failure. MITOXANTRONE dosage: 12 MG/M2 Q3W. During the same period patient was treated with PREDNISONE, GOSERELIN, BICALUTAMIDE. Patient died.
Mitoxantrone Side Effects Report #5160875-8
Physician from ITALY reported MITOXANTRONE problem on Nov 08, 2006. Female patient, 35 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, nuclear magnetic resonance imaging abnormal, spinal disorder, stem cell transplant, treatment related secondary malignancy. MITOXANTRONE dosage: unknown. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5382147-9
MITOXANTRONE problem was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5389490-8
MITOXANTRONE problem was reported by a Physician from BELGIUM on July 12, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic, pneumonitis. MITOXANTRONE dosage: unknown. During the same period patient was treated with CASPOFUNGIN ACETATE, GEMTUZUMAB OZOGAMICIN, GLAZIDIM, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient died on 07/25/2006.
Mitoxantrone Side Effects Report #5395496-5
Physician from ITALY reported MITOXANTRONE problem on July 18, 2007. Male patient, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: pulmonary alveolar haemorrhage. MITOXANTRONE dosage: 7 MG/M^2 - 39 MG. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient recovered.
Mitoxantrone Side Effects Report #5400629-8
MITOXANTRONE problem was reported by a Physician from BELGIUM on July 19, 2007. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic, pneumonitis. MITOXANTRONE dosage: unknown. During the same period patient was treated with CASPOFUNGIN ACETATE, GEMTUZUMAB OZOGAMICIN, GLAZIDIM, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient died on 07/25/2006.
Mitoxantrone Side Effects Report #5404707-9
Consumer or non-health professional from GERMANY reported MITOXANTRONE problem on June 19, 2007. Female patient was diagnosed with secondary progressive multiple sclerosis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: cardiac septal defect, pulmonary hypertension, tricuspid valve disease. MITOXANTRONE dosage: unknown. Patient recovered.
Mitoxantrone Side Effects Report #5404714-6
MITOXANTRONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 11, 2007. Male patient, 73 years of age, was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: diplopia. MITOXANTRONE dosage: 10.5 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, MABTHERA. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5404973-X
Health Professional from UNITED STATES reported MITOXANTRONE problem on July 25, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: agitation, aspergillosis, cerebral infarction, febrile neutropenia, hypertension, hypotension, lung infection pseudomonal, mucosal inflammation, oedema. MITOXANTRONE dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient died on 03/14/2007.
Mitoxantrone Side Effects Report #5427706-X
MITOXANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.